TL;DR
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today’s Oct. 25, 2026, roundup collected seven comments from researchers and clinicians on recent medical developments. The topics included dengue outbreaks in Florida, unanswered questions about dupilumab exposure during pregnancy, menopause treatments, advance care planning and early-stage research in Parkinson’s disease.
MedPage Today published a weekly roundup on October 25 featuring seven remarks from clinicians and researchers on recent medical news, including dengue outbreaks in Florida, pregnancy exposure to dupilumab and research into menopause symptoms and Parkinson’s disease. The comments capture reactions to separate reports and cases; they do not represent a single study or a unified set of findings.
Adam Waickman, a researcher at SUNY Upstate Medical University, used the phrase “The cat is out of the bag” while discussing large dengue outbreaks in Florida and warning about possible further spread in the United States. The roundup does not provide case counts, locations beyond Florida, or a forecast for how the outbreak may develop.
Other comments addressed distinct questions. Christina Chambers of the University of California San Diego said it remains an open question whether early-life exposure to dupilumab could affect children’s long-term risk of atopic conditions. The roundup says data indicated exposure during pregnancy appeared safe, but does not provide study details or establish a long-term effect.
The remaining remarks covered an incorrect multiple sclerosis diagnosis discussed by Cleveland Clinic’s Marisa McGinley; a rare infant case involving a second colon, described by Lynn Sinitsky of West Hertfordshire Teaching Hospitals; and research on non-hormonal menopause drugs, advance care planning for people nearing kidney failure, and psilocybin research in Parkinson’s disease. Each item is presented briefly, without enough methodological detail to assess the underlying evidence on its own.
Seven Comments, Separate Evidence
The roundup brings together developments with different levels and types of evidence, from an outbreak warning to a rare clinical case and research findings. Readers should not treat the comments as interchangeable proof: a researcher’s reaction, a case report and a meta-analysis answer different questions.
The distinction matters especially for potential health effects and treatment decisions. The quoted remarks can point readers toward issues worth following, but the source provides limited detail about study size, methods, limitations or clinical recommendations. The collection is best read as a snapshot of current discussion, not as medical guidance or a comprehensive account of the evidence.
Products Worth Considering
Withings Sleep Under-Mattress Sleep Tracking Pad
Levoit Eleva 300X HEPA Air Purifier for Home and Bedroom
Hyperice Normatec 3 Leg Compression Boots – Standard Size
As an affiliate, we earn on qualifying purchases.
The Reports Behind the Remarks
MedPage Today’s item is a short, recurring compilation of quotes heard by its reporters, rather than a full-length report on any one topic. The October 25 edition includes seven speakers from universities, hospitals and health systems. Their comments refer to separate stories and research, and the roundup’s brief format leaves much of that source material outside the article.
Among the remarks, JoAnn Manson of Harvard Medical School characterized a meta-analysis of non-hormonal menopause drugs as “good news for women” because it found the drugs could ease sleep disturbances. Angelo Volandes of Dartmouth Health discussed a video decision-support tool that research said increased advance care planning documentation among patients nearing kidney failure. Ellen Bradley of the University of California San Francisco said a small trial linking psilocybin with reduced markers of systemic inflammation and mitochondrial stress in people with Parkinson’s disease raised biological questions for researchers to pursue.
““This is good news for women.””
— JoAnn Manson, MD, MPH, DrPH, Harvard Medical School
Evidence Details Still Missing
The roundup does not supply the underlying studies, their publication details, sample sizes or methods. It is therefore not possible from this item alone to judge the strength of the evidence behind the reported findings or the extent to which they may apply to other patients.
Several points remain explicitly unresolved. The long-term effects, if any, of early-life exposure to dupilumab are not established in the roundup, and the potential spread of dengue beyond Florida is described as a warning rather than a confirmed projection. The small Parkinson’s trial reports changes in biological markers; the source does not say that psilocybin improved symptoms or altered the course of the disease.
Follow the Underlying Research
The next steps depend on each separate development. Readers seeking further detail will need to consult the original reports and studies behind the quotes, including the evidence on pregnancy exposure to dupilumab, the menopause-drug meta-analysis and the Parkinson’s trial. The roundup does not announce a shared follow-up date or a single next milestone.
For dengue, the item offers no updated case figures or official forecast, so changes in the outbreak and any public-health guidance would need to be checked through subsequent reporting and local health authorities. Longer-term research will also be needed to address the questions Chambers and Bradley raised about possible effects and biological mechanisms.
Key Questions
What did MedPage Today publish?
It published a seven-quote weekly roundup on October 25, 2026, collecting remarks from clinicians and researchers about separate medical stories.
What was said about dengue?
Adam Waickman discussed large outbreaks in Florida and warned of possible further spread across the United States. The roundup gives no case count or specific forecast.
Does the roundup show that dupilumab exposure during pregnancy affects children long term?
No. The roundup says pregnancy exposure appeared safe in the data it refers to, while the possible long-term effects of early-life exposure remain an open question.
Did the psilocybin trial show that the drug treats Parkinson’s disease?
The roundup describes a small trial linking psilocybin with reduced markers of systemic inflammation and mitochondrial stress. It does not report evidence that the drug treats Parkinson’s symptoms or changes the disease’s course.
Source: rss
